Simplex Trading’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
– Sell
-131
Closed -$11.5K – 9232
2023
Q4
$9K Buy
+131
New +$7.74K ﹤0.01% 7511
2023
Q2
– Sell
-1
Closed -$100 – 9327
2023
Q1
$0 Sell
1
-753
-100% -$115K ﹤0.01% 9411
2022
Q4
$130K Buy
754
+494
+190% +$325K ﹤0.01% 4756
2022
Q3
$249K Buy
260
+7
+3% +$6.95K ﹤0.01% 4331
2022
Q2
$169K Buy
253
+217
+603% +$135K ﹤0.01% 4828
2022
Q1
$25K Sell
36
-164
-82% -$127K ﹤0.01% 7988
2021
Q4
$181K Buy
+200
New +$190K ﹤0.01% 5332
2021
Q2
– Sell
-66
Closed -$45.8K – 10267
2021
Q1
$48K Sell
66
-145
-69% -$117K ﹤0.01% 6667
2020
Q4
$163K Buy
211
+62
+42% +$48.9K ﹤0.01% 4875
2020
Q3
$147K Buy
149
+96
+181% +$102K ﹤0.01% 4480
2020
Q2
$55K Sell
53
-483
-90% -$486K ﹤0.01% 5402
2020
Q1
$434K Buy
+536
New +$560K ﹤0.01% 2742
2019
Q4
– Sell
-42
Closed -$67.7K – 7519
2019
Q3
$55K Buy
+42
New +$66.8K ﹤0.01% 4927

Other funds holding GOSS

Simplex Trading's GOSS Position: Q1 2024 in Review

Simplex Trading sold out of Gossamer Bio (GOSS) in Q1 2024, closing a stake of 131 shares — an estimated $11.5K sold.

Simplex Trading first reported a position in GOSS in Q3 2019 and held it in 13 quarters. The position peaked at $434K in Q1 2020. 108 funds tracked by Wall St. Rank hold GOSS as of Q1 2024.

  • Simplex Trading reported no remaining Gossamer Bio position as of Q1 2024 after selling out during the quarter.
  • Simplex Trading sold 131 Gossamer Bio shares in Q1 2024, an estimated $11.5K.
  • Simplex Trading first reported a position in Gossamer Bio in Q3 2019 and held it in 13 quarters.
  • Simplex Trading's Gossamer Bio position peaked at $434K in Q1 2020.
  • 108 funds tracked by Wall St. Rank held Gossamer Bio as of Q1 2024.

Based on Simplex Trading's 13F filing for Q1 2024, filed 25 Apr 2024.